American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Microsoft
MSFT
|
+$316M |
| 2 |
Abbott
ABT
|
+$275M |
| 3 |
Lockheed Martin
LMT
|
+$207M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$149M |
| 5 |
Visa
V
|
+$145M |
Top Sells
| 1 |
Occidental Petroleum
OXY
|
+$268M |
| 2 |
Procter & Gamble
PG
|
+$253M |
| 3 |
Dollar Tree
DLTR
|
+$250M |
| 4 |
DXC Technology
DXC
|
+$206M |
| 5 |
General Mills
GIS
|
+$194M |
Sector Composition
| 1 | Financials | 16.32% |
| 2 | Technology | 13.77% |
| 3 | Healthcare | 13.43% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Acadia Pharmaceuticals
ACAD
$3.98B
| $2.27M | ﹤0.01% |
+148,748
| New | +$2.27M |
|
1002
Artisan Partners
APAM
$3.27B
| $2.26M | ﹤0.01% |
75,013
-244
| -0.3% | -$7.36K |
|
|
UN
1003
DELISTED
Unilever NV New York Registry Shares
UN
| $2.24M | ﹤0.01% |
40,271
+7,304
| +22% | +$407K |
|
|
OMN
1004
DELISTED
OMNOVA Solutions Inc.
OMN
| $2.24M | ﹤0.01% |
214,920
+2,496
| +1% | +$26K |
|
1005
AnaptysBio
ANAB
$655M
| $2.17M | ﹤0.01% |
30,596
+8,044
| +36% | +$572K |
|
1006
Patrick Industries
PATK
$3.67B
| $2.17M | ﹤0.01% |
57,285
| – | – |
|
1007
Crocs
CROX
$4.23B
| $2.17M | ﹤0.01% |
123,050
| – | – |
|
|
CCXI
1008
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.16M | ﹤0.01% |
163,871
+132,592
| +424% | +$1.75M |
|
1009
Brinker International
EAT
$6.84B
| $2.16M | ﹤0.01% |
45,279
+625
| +1% | +$29.7K |
|
1010
Madrigal Pharmaceuticals
MDGL
$9.63B
| $2.15M | ﹤0.01% |
+7,691
| New | +$2.15M |
|
|
ATHN
1011
DELISTED
Athenahealth, Inc.
ATHN
| $2.14M | ﹤0.01% |
+13,437
| New | +$2.14M |
|
1012
Movado Group
MOV
$438M
| $2.1M | ﹤0.01% |
+43,479
| New | +$2.1M |
|
1013
Shoe Carnival
SCVL
$636M
| $2.09M | ﹤0.01% |
+128,678
| New | +$2.09M |
|
|
MBFI
1014
DELISTED
MB Financial Corp
MBFI
| $2.04M | ﹤0.01% |
43,764
-5,700
| -12% | -$266K |
|
|
SCG
1015
DELISTED
Scana
SCG
| $2.02M | ﹤0.01% |
+52,512
| New | +$2.02M |
|
1016
Cohu
COHU
$964M
| $2.02M | ﹤0.01% |
82,303
| – | – |
|
1017
Gildan
GIL
$8.03B
| $2.01M | ﹤0.01% |
71,450
-19,180
| -21% | -$540K |
|
|
EVRI
1018
DELISTED
Everi Holdings
EVRI
| $2.01M | ﹤0.01% |
279,479
+11,472
| +4% | +$82.6K |
|
1019
Boston Beer
SAM
$2.36B
| $2M | ﹤0.01% |
6,682
-29,753
| -82% | -$8.92M |
|
|
CVG
1020
DELISTED
Convergys
CVG
| $1.97M | ﹤0.01% |
80,629
-162,383
| -67% | -$3.97M |
|
1021
Nasdaq
NDAQ
$53.9B
| $1.95M | ﹤0.01% |
63,924
-2,189,259
| -97% | -$66.6M |
|
1022
Marcus & Millichap
MMI
$1.26B
| $1.94M | ﹤0.01% |
+49,720
| New | +$1.94M |
|
1023
TriCo Bancshares
TCBK
$1.48B
| $1.93M | ﹤0.01% |
51,402
+4,142
| +9% | +$155K |
|
1024
MarineMax
HZO
$556M
| $1.9M | ﹤0.01% |
100,333
-376,422
| -79% | -$7.13M |
|
|
HIFR
1025
DELISTED
InfraREIT, Inc.
HIFR
| $1.89M | ﹤0.01% |
85,234
-658
| -0.8% | -$14.6K |
|